Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma.
about
Biomarkers for hepatocellular carcinomamiR-190-mediated downregulation of PHLPP contributes to arsenic-induced Akt activation and carcinogenesisTissue- and Serum-Associated Biomarkers of Hepatocellular CarcinomaMicroRNAs in the Evaluation and Potential Treatment of Liver DiseasesMicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis B- and C-related-hepatocellular-carcinomaMicroRNAs as Biomarkers for Liver Disease and Hepatocellular CarcinomaMicroRNAs Expressed during Viral Infection: Biomarker Potential and Therapeutic ConsiderationsMicroRNAs as Important Players in Host-hepatitis B Virus InteractionsPredictive biomarkers of sorafenib efficacy in advanced hepatocellular carcinoma: Are we getting there?MicroRNA expression in hepatitis C virus-related malignancies: A brief reviewMicroRNAs may solve the mystery of chronic hepatitis B virus infectionThe role of microRNAs in human liver cancersMicroRNAs, hepatitis C virus, and HCV/HIV-1 co-infection: new insights in pathogenesis and therapyHepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseasesRole of innate immunity in the development of hepatocellular carcinomaEmerging role of microRNAs in liver diseasesUpregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture modelHepatitis C virus and hepatocarcinogenesisMolecular classification and novel targets in hepatocellular carcinoma: recent advancementsMicroRNA-190 regulates FOXP2 genes in human gastric cancerVariation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriersProgression from Excessive to Deficient Syndromes in Chronic Hepatitis B: A Dynamical Network Analysis of miRNA Array DataHepatitis C virus induced miR200c down modulates FAP-1, a negative regulator of Src signaling and promotes hepatic fibrosisMiRNA-99a directly regulates AGO2 through translational repression in hepatocellular carcinomaAlcohol-dysregulated microRNAs in hepatitis B virus-related hepatocellular carcinoma.Validation of a serum microRNA panel as biomarkers for early diagnosis of hepatocellular carcinoma post-hepatitis C infection in Egyptian patientsThe progression of liver fibrosis is related with overexpression of the miR-199 and 200 familiesENCODE tiling array analysis identifies differentially expressed annotated and novel 5' capped RNAs in hepatitis C infected liver.MicroRNAs in liver diseaseReduction of microRNA 122 expression in IFNL3 CT/TT carriers and during progression of fibrosis in patients with chronic hepatitis CCarboxyl-terminal truncated HBx regulates a distinct microRNA transcription program in hepatocellular carcinoma developmentMicroRNAs are expressed and processed by human primary macrophages.Comparative miRNA expression profiles in individuals with latent and active tuberculosis.Therapeutics Based on microRNA: A New Approach for Liver CancerPlasma microRNA profiles in rat models of hepatocellular injury, cholestasis, and steatosis.Circulating microRNAs in hepatitis B virus-infected patients.Identification of microRNAs during rat liver regeneration after partial hepatectomy and modulation by ursodeoxycholic acidCirculating hepatitis B surface antigen particles carry hepatocellular microRNAs.Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection.MicroRNA-224 is up-regulated in hepatocellular carcinoma through epigenetic mechanisms.
P2860
Q21285158-F72FCDCB-D31A-4B09-8015-0716BB6B8E04Q23916198-BC313F4E-0A13-4EB9-9CFA-AC20C5484FF1Q26743361-D42D05E2-4FB0-4C41-846A-68A1C9984E4BQ26750448-A7277938-78D8-41CA-BC5E-D8BFA99402F1Q26751392-8854BD53-2C95-4532-8253-B7273E0077D5Q26765476-4B24F0C0-3F49-4A9C-AE69-13B068AFC1B1Q26773183-22D3B47E-F76A-40D7-AB97-0BA763779B0BQ26781737-71A23F93-85D7-4720-94A2-F910BB100F09Q26784218-EE60B26E-7DC5-44C1-A6F3-DA57F083C337Q26801181-83902223-D52A-440B-87B6-56FAEA39ECD7Q26827668-B166F9B6-F3BB-477A-A279-1421847C30D9Q26861699-D2B3DEF2-4098-41AE-B2CD-B2F209DD9734Q27015778-4DC63701-D0C6-4C36-A032-0D3CDDB8C769Q27024630-1DB9CCC8-D2E1-4BCE-A76C-293A37258931Q27024780-360AEFD1-A01A-4A81-895B-F4D4FE17B8E1Q27490492-AA9C6C02-0A5F-44AC-B732-3C1359764641Q28114928-0CC72F3D-47E7-4359-A38A-CC487AA07AA9Q28283484-5A87E218-D45D-4D49-A9F3-E82E3DF6966EQ28383646-1B180A71-0B7D-4B5A-A4E4-8168A355A4FAQ28397734-BB577C65-EF6D-4C7D-8508-D3A73B176428Q28943479-841611FF-6249-4CDA-AC8D-7F1967C21983Q30629629-5AE3CC0C-523A-4E73-B5F7-722814096D15Q31126487-C98BFAB8-8E43-4235-ABAD-D686A515936EQ33555052-A8DBBB94-C8B2-4451-8A63-DB6F69471D79Q33746155-6E668A17-5AE7-42E3-8677-D80DD9EF6365Q33786041-E92979F8-816F-4BFB-B87B-8296E4FC674CQ33808955-C588DE9D-95D9-4626-9650-02F837B13F48Q33832050-1BFB7F64-8613-4C66-85B4-95EF0E086C64Q33880442-D046FDCA-C6BC-420B-9EA3-C8FE654C66F3Q33887760-67727A60-8245-4BAD-A114-5CBB32A107E3Q33988586-BBBB5622-90AC-466A-8944-1E51E0E5BCA1Q34003697-D6425D62-0677-4CEC-85E6-A4F4B3BB5259Q34049337-04DFBBBB-B026-4573-9895-317D5DBD822CQ34152847-FD43DA05-448A-4286-8FB5-8CF3565C1CE4Q34169945-531CCE15-46B0-47F0-9175-E0E3B044AB02Q34194362-92DB92D8-B379-4132-96D1-D86E2A6616D2Q34212063-DD97D396-F86C-465E-94FC-F8E3DCF3CBFAQ34217300-16F3619E-D2B7-49F4-822E-5EF8FDFCDD1CQ34252178-ADB45349-3F3A-4F3C-971E-31AFE7FFE134Q34264405-BA59C4F7-3BB4-477B-AA25-AA064E6054EA
P2860
Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Differential microRNA expressi ...... n to hepatocellular carcinoma.
@en
Differential microRNA expressi ...... n to hepatocellular carcinoma.
@nl
type
label
Differential microRNA expressi ...... n to hepatocellular carcinoma.
@en
Differential microRNA expressi ...... n to hepatocellular carcinoma.
@nl
prefLabel
Differential microRNA expressi ...... n to hepatocellular carcinoma.
@en
Differential microRNA expressi ...... n to hepatocellular carcinoma.
@nl
P2093
P2860
P921
P356
P1433
P1476
Differential microRNA expressi ...... n to hepatocellular carcinoma.
@en
P2093
Hajime Sunakozaka
Hajime Takatori
Katsuhisa Horimoto
Masao Honda
Ryuhei Nishino
Shuichi Kaneko
Shunsuke Ura
Taro Yamashita
Teruyuki Ueda
Yoshio Sakai
P2860
P304
P356
10.1002/HEP.22749
P407
P577
2009-04-01T00:00:00Z